510(k) device
EchoPAC Software Only / EchoPAC Plug-in (v211)
GE Medical Systems Ultrasound and Primary Care Diagnostics · Automated Radiological Image Processing Software (QIH, Class II) · First FDA decision Jul 22, 2022, newest Sep 16, 2026
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
1
Naming "EchoPAC"
MAUDE reports
0
Brand "EchoPAC", since 2015
PubMed studies
195
Mentioning "EchoPAC"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing EchoPAC Software Only / EchoPAC Plug-in (v211)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K261623 · Decided Sep 16, 2026 · 124 days after receipt
Device type: Automated Radiological Image Processing Software (QIH) · Radiology & Imaging
K251342 · Decided Jul 16, 2025 · 77 days after receipt
Device type: Automated Radiological Image Processing Software (QIH) · Radiology & Imaging
K220940 · Decided Jul 22, 2022 · 113 days after receipt
Device type: Automated Radiological Image Processing Software (QIH) · Radiology & Imaging
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "EchoPAC", any status and sponsor, newest update first.
Pulsify MedicalNot on our public-company list
NCT05734664 · 8 participants · Start Oct 19, 2022 · Primary completion Jan 23, 2023
Device: Pulsify sensor; State-of-the-art ultrasound equipment · For: Cardiac Output Measurements; Healthy Subjects
Sites: Leuven, Belgium
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "EchoPAC", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QIH
10 reports: 9 malfunction, 1 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "EchoPAC"[tiab]. The summary above synthesizes these.
- Echocardiographic Reference Ranges of Global Longitudinal Strain for All Cardiac Chambers Using Guideline-Directed Dedicated Views.
Nyberg J, Jakobsen EO, Østvik A, et al. · JACC Cardiovasc Imaging · 2023Research Support, Non-U.S. Gov't
- Left Ventricular "Longitudinal Rotation" and Conduction Abnormalities-A New Outlook on Dyssynchrony.
Marai I, Haddad R, Andria N, et al. · J Clin Med · 2023
- Echocardiographic Reference Ranges of Non-invasive Myocardial Work Indices in Children.
Pham TTM, Truong VT, Vu PN, et al. · Pediatr Cardiol · 2022
- Intervendor Agreement for Right Ventricular Global Longitudinal Strain in Children.
Aly D, Ramlogan S, France R, et al. · J Am Soc Echocardiogr · 2021
- Artificial Intelligence for Automatic Measurement of Left Ventricular Strain in Echocardiography.
Salte IM, Østvik A, Smistad E, et al. · JACC Cardiovasc Imaging · 2021Research Support, Non-U.S. Gov't
- Association between the triglyceride-glucose index and subclinical left ventricular systolic dysfunction in obese patients.
Li GA, Huang J, Wang J, et al. · Cardiovasc Diabetol · 2024Research Support, Non-U.S. Gov't
- Impact of inter-vendor variability on evaluation of left ventricular mechanical dispersion.
Appadurai V, Scalia GM, Lau K, et al. · Echocardiography · 2022
- Noninvasive assessment of myocardial work during left ventricular isovolumic relaxation in patients with diastolic dysfunction.
Guo Y, Wang X, Yang CG, et al. · BMC Cardiovasc Disord · 2023Research Support, Non-U.S. Gov't
- Left ventricular global work index and prediction of cardiovascular mortality after transcatheter aortic valve implantation.
Anwer S, Nussbaum S, E Winkler N, et al. · Int J Cardiol · 2024Research Support, Non-U.S. Gov't
- Inter-vendor variability and reproducibility of subcostal left ventricular longitudinal strain.
Gong FF, Nishtala A, Chow K, et al. · Int J Cardiovasc Imaging · 2021
- How Does Regional Hypertrophy Affect Strain Measurements With Different Speckle-Tracking Methods?
Dobrovie M, Buzy S, Ünlü S, et al. · J Am Soc Echocardiogr · 2019Research Support, Non-U.S. Gov't
- Inter-vendor comparison of left atrial strain using layer specific strain analysis.
Ferkh A, Stefani L, Trivedi SJ, et al. · Int J Cardiovasc Imaging · 2021Comparative Study
Other devices of this type
Also filed under product code QIH.
- syngo.via MI WorkflowsSiemens Medical Solutions USA, Inc. · 510(k) 2025
- LVivo Software ApplicationDia Imaging Analysis, Ltd. · 510(k) 2025
- PeekMed webPeek Health, S.A. · 510(k) 2025
- BriefCase-QuantificationAidoc Medical , Ltd. · 510(k) 2024
- Rapid Platform (R6.7)Ischemaview, Inc. · 510(k) 2026
- BoneMRIMriguidance B.V. · 510(k) 2026
- Acorn 3D Software (AC-SEG-4009)Mighty Oak Medical · 510(k) 2026
- MI View&GOSiemens Medical Solutions USA, Inc. · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.